KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway

References

• Shang N, Wang H, Bank T, et al. Focal adhesion kinase and β-catenin cooperate to induce hepatocellular carcinoma. Hepatology. 2019;70:1631–1645. doi:10.1002/hep.3070731069844
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, et al. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70:1298–1316. doi:10.1002/hep.3067131004447
   PubMed Web of Science ®Google Scholar
• Yang X, Sun L, Wang L, et al. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4. Biomed Pharmacother. 2019;118:109386. doi:10.1016/j.biopha.2019.10938631545291
   PubMed Web of Science ®Google Scholar
• Liu J, Li T, Zhang L, Xu A. The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among asian patients with chronic hepatitis B: a systematic review. Hepatology. 2019;70:1045–1055. doi:10.1002/hep.3047430561829
   PubMed Web of Science ®Google Scholar
• He T, Zhang N, Wang L, et al. GPR43 regulates HBV X protein (HBx)-induced inflammatory response in human LO2 hepatocytes. Biomed Pharmacother. 2020;123:109737. doi:10.1016/j.biopha.2019.10973731884344
   PubMed Web of Science ®Google Scholar
• Gao Q, Zhu H, Dong L, et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell. 2019;179:1240. doi:10.1016/j.cell.2019.10.03831730861
   PubMed Web of Science ®Google Scholar
• Li YM, Liu Z-Y, Wang J-C, et al. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis. Hepatology. 2019;70:1564–1581. doi:10.1002/hep.3067631021443
   PubMed Web of Science ®Google Scholar
• Tan E, Sandroussi C. Liver resection in elderly patients over the age of 70 with primary liver cancer: a retrospective analysis. Ann Oncol. 2019;30(Suppl 4):iv93. doi:10.1093/annonc/mdz155.337
   Google Scholar
• Chiu V, Hogen R, Sher L, et al. Telomerase variants in patients with cirrhosis awaiting liver transplantation. Hepatology. 2019;69:2652–2663. doi:10.1002/hep.3055730964210
   PubMed Web of Science ®Google Scholar
• Consonni S, Mainini V, Pizzardi A, et al. Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach. Arch Gynecol Obstet. 2014;289:299–306. doi:10.1007/s00404-013-2967-923872981
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Y, Fan H, Zhang Z, Li N. miR-125b-5p inhibits breast cancer cell proliferation, migration and invasion by targeting KIAA1522. Biochem Biophys Res Commun. 2018;504:277–282. doi:10.1016/j.bbrc.2018.08.17230177391
   PubMed Web of Science ®Google Scholar
• Xie ZH, Yu J, Shang L, et al. KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity. Onco Targets Ther. 2017;10:3743–3754. doi:10.2147/OTT.S14261028794639
   PubMed Web of Science ®Google Scholar
• Liu YZ, Yang H, Cao J, et al. KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer. Sci Rep. 2016;6:24786. doi:10.1038/srep2478627098511
   PubMed Web of Science ®Google Scholar
• Liu YZ, Jiang -Y-Y, Wang B-S, et al. A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens. Cancer Cytopathol. 2014;122:833–841. doi:10.1002/cncy.2146125045014
   PubMed Web of Science ®Google Scholar
• Wu F, Hu N, Li Y, et al. Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC. Cell Oncol. 2012;35:175–180. doi:10.1007/s13402-012-0075-7
   PubMed Web of Science ®Google Scholar
• Chen X, Huan H, Liu C, et al. Deacetylation of β-catenin by SIRT1 regulates self-renewal and oncogenesis of liver cancer stem cells. Cancer Lett. 2019;463:1–10. doi:10.1016/j.canlet.2019.07.02131394122
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Z, Xuan Z, et al. Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis. J Exp Clin Cancer Res. 2018;37:320. doi:10.1186/s13046-018-0993-y30572959
   PubMed Web of Science ®Google Scholar
• Liu X, Pu W, He H, et al. Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer. Cancer Lett. 2019;458:76–85. doi:10.1016/j.canlet.2019.05.01631125641
   PubMed Web of Science ®Google Scholar
• Zhang Q, He Y, Luo N, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829–845 e820. doi:10.1016/j.cell.2019.10.00331675496
   PubMed Web of Science ®Google Scholar
• Teufel M, Seidel H, Köchert K, et al. Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma. Gastroenterology. 2019;156:1731–1741. doi:10.1053/j.gastro.2019.01.26130738047
   PubMed Web of Science ®Google Scholar
• Agelopoulos K, Richter GHS, Schmidt E, et al. Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in Ewing sarcoma. Clin Cancer Res. 2015;21:4935–4946. doi:10.1158/1078-0432.CCR-14-274426179511
   PubMed Web of Science ®Google Scholar
• Feng T, Zhou L, Wang Z, et al. Dual-stimuli responsive nanotheranostics for mild hyperthermia enhanced inhibition of Wnt/β-catenin signaling. Biomaterials. 2020;232:119709. doi:10.1016/j.biomaterials.2019.11970931896513
   PubMed Web of Science ®Google Scholar
• Pradhan-Sundd T, Kosar K, Saggi H, et al. Wnt/beta-catenin signaling plays a protective role in the Mdr2 knockout murine model of cholestatic liver disease. Hepatology. 2019. doi:10.1002/hep.30927
   PubMed Web of Science ®Google Scholar
• Choi JH, Zhong X, McAlpine W, et al. LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. Science. 2019;364:eaau0812. doi:10.1126/science.aau081231073040
   PubMed Web of Science ®Google Scholar
• Hubner K, Cabochette P, Diéguez-Hurtado R, et al. Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling. Nat Commun. 2018;9(1):4860. doi:10.1038/s41467-018-07302-x30451830
   PubMed Web of Science ®Google Scholar
• Yin N, Liu Y, Khoor A, et al. Protein kinase Cι and wnt/β-catenin signaling: alternative pathways to Kras/Trp53-driven lung adenocarcinoma. Cancer Cell. 2019;36:156–167 e157. doi:10.1016/j.ccell.2019.07.00231378680
   PubMed Web of Science ®Google Scholar
• Kabiri Z, Greicius G, Zaribafzadeh H, et al. Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells. J Clin Invest. 2018;128:3806–3812. doi:10.1172/JCI9932530059017
   PubMed Web of Science ®Google Scholar
• Wang B, Tian T, Kalland KH, Ke X, Qu Y. Targeting Wnt/β-catenin signaling for cancer immunotherapy. Trends Pharmacol Sci. 2018;39:648–658. doi:10.1016/j.tips.2018.03.00829678298
   PubMed Web of Science ®Google Scholar
• Tang Y, Shen J, Zhang F, Yang FY, Liu M. Human serum albumin attenuates global cerebral ischemia/reperfusion-induced brain injury in a Wnt/β-catenin/ROS signaling-dependent manner in rats. Biomed Pharmacother. 2019;115:108871. doi:10.1016/j.biopha.2019.10887131026729
   PubMed Web of Science ®Google Scholar
• Yao Y, Hua Q, Zhou Y, Shen H. CircRNA has_circ_0001946 promotes cell growth in lung adenocarcinoma by regulating miR-135a-5p/SIRT1 axis and activating Wnt/β-catenin signaling pathway. Biomed Pharmacother. 2019;111:1367–1375. doi:10.1016/j.biopha.2018.12.12030841451
   PubMed Web of Science ®Google Scholar
• Fan Z, Duan J, Wang L, et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling. Cancer Lett. 2019;450:132–143. doi:10.1016/j.canlet.2019.02.04030849480
   PubMed Web of Science ®Google Scholar